The end of an era?

Nature Reviews Drug Discovery

Volumn 6, Issue 1, 2007, Pages 28-

  Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CYTOTOXIC AGENT; DAPTOMYCIN; LINEZOLID; LIPOPEPTIDE; NALIDIXIC ACID; NEW DRUG; PENICILLIN G; POLYKETIDE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENOME; DRUG APPROVAL; DRUG INDUSTRY; DRUG RESEARCH; EDITORIAL; FUNDING; GENETIC ENGINEERING; HUMAN; INFECTION; LIFE EXPECTANCY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PROTEIN ENGINEERING;

EID: 33845894678     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2223     Document Type: Editorial

References (3)

1. Infectious Diseases Society of America. Bad Bugs No Drugs. As antibiotic discovery stagnates a public health crisis brews [online], (2004).
2. National Research Council. Treating Infectious Diseases in a Microbial World: Report of Two Workshops (The National Academies Press, Washington DC, 2005).
3. Canadian Institutes for Health Research. Novel approaches to Antibiotics; Is time running out? Workshop Report [online], (2005).